Asian American Medical Group Limited (ASX:AJJ) Annual Report 2020



The latest annual report of Asian American Medical Group Limited (AJJ) was published on 31 Aug 2020. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - AJJ Annual Results

Amounts in SGD

Total Revenue
7.21M
Gross Profit
-366.32k
EBIT
-2.61M
Net Tangible Assets
11.17M
Net Income
-2.46M
Capital Expenditures
-810.17k

AJJ Income Statement 2020 Annual Report

As per the latest Income Statement of AJJ, the Net revenue decreased by S$-461526 (-6%) compared to the previous period. The operating income in 2020 decreased by S$-526041 (-25%). The net income as per the annual report was -2.46M which decreased by S$-404247 (-20%) compared to previous year.

Income Statement Report (2020/2019)

20202019
Total Revenue7.21M7.67M
Gross Profit-366.32k-1.22M
Operating Income-2.61M-2.08M
Income Before Tax-2.58M-2.03M
Net Income-2.46M-2.05M

Balance Sheet - AJJ 2020 Annual Report

Read further: AJJ Balance Sheet Detailed Analysis

The latest balance sheet from annual result of Asian American Medical Group Limited showed the company reduced the cash on balance sheet by S$-3.75M (-74%). The Net tangible assets of AJJ on the balance sheet were at 11.17M which is S$-1.64M (-13%) less than previous annual report. The total stockholder equity also decreased by S$-1.64M (-13%) compared to previous reporting period.

Balance Sheet Statement Report (2020/2019)

20202019
Cash1.33M5.09M
Total Assets16.85M 17.41M
Long Term Debt--
Total Liabilities4.89M 3.86M
Total Shareholder Equity11.17M12.81M
Net Tangible Assets11.17M12.81M

Cash Flow Statement - AJJ 2020 Annual Report

The 2020 annual cash flow statement of Asian American Medical Group Limited showed that the net income decreased by S$-404247 (-20%) compared to previous reporting period. Also the capital expenditure of AJJ decreased by S$-269234 (-50%).

As of 2020, the total cash from investing activities was -809.96k and total cash from financing activities was -619.81k.

Cash Flow Statement Report (2020/2019)

20202019
Net Income-2.46M-2.05M
Capital Expenditures-810.17k-540.94k
Dividends Paid--
Total Cash From From Investing Activities-809.96k-490.81k
Total Cash From From Financing Activities-619.81k1.05M

Asian American Medical Group Limited Annual Report History

Income Statement

Income Statement history of Asian American Medical Group Limited (ASX:AJJ)

31 Aug 202031 Aug 201931 Aug 201831 Aug 2017
Total Revenue7.21M7.67M17.48M15.17M
Cost Of Revenue7.58M8.89M15.84M15.94M
Gross Profit-366.32k-1.22M1.64M-774.67k
Research Development----
Selling General Administrative89.29k611.48k641.27k574.59k
Non Recurring----
Other Operating Expenses1.46M211.29k628.12k1.09M
Total Operating Expenses9.82M9.75M17.15M17.51M
Operating Income-2.61M-2.08M322.05k-2.34M
Total Other Income Expense Net31.66k48.83k1.57M-536.65k
Ebit-2.61M-2.08M322.05k-2.34M
Interest Expense-117.74k-117.74k-117.74k-117.74k
Income Before Tax-2.58M-2.03M1.9M-2.88M
Income Tax Expense---169.89k149.38k
Minority Interest792.57k739.2k723.43k174.43k
Net Income From Continuing Ops-2.58M-2.03M2.07M-3.03M
Discontinued Operations174.36k-27.3k-27.3k-27.3k
Extraordinary Items----
Effect Of Accounting Charges----
Other Items----
Net Income-2.46M-2.05M1.95M-3.09M
Net Income Applicable To Common Shares-2.46M-2.05M1.95M-3.09M

Balance Sheet Statement

Balance Sheet Statement history of Asian American Medical Group Limited (ASX:AJJ)

31 Aug 202031 Aug 201931 Aug 201831 Aug 2017
Cash1.33M5.09M8.93M9.17M
Short Term Investments145.62k404.14k188.82k155.44k
Net Receivables1.11M2.12M2.63M5.98M
Inventory104.98k157.28k192.69k165.62k
Other Current Assets2.1M---
Total Current Assets4.79M7.77M11.94M15.48M
Long Term Investments66.29k69.18k69.25k-
Property Plant Equipment11.99M9.4M8.97M69.93k
Total Assets16.85M17.41M21.16M15.55M
Accounts Payable735.87k2.9M3.62M5.03M
Other Current Liab1.56M752.67k1.84M745.28k
Other Liab75.92k75.92k75.92k-
Minority Interest792.57k739.2k723.43k174.43k
Total Current Liabilities3.45M3.79M5.64M5.94M
Total Liab4.89M3.86M5.72M5.94M
Common Stock18.22M18.22M17.23M12.93M
Retained Earnings-6.18M-3.72M-1.7M-3.65M
Treasury Stock-870.54k-1.69M-812.3k150.79k
Other Stockholder Equity-870.54k-1.69M-812.3k150.79k
Total Stockholder Equity11.17M12.81M14.71M9.43M
Net Tangible Assets11.17M12.81M14.71M9.43M
Long Term Debt----

Cash Flow Statement

Cash Flow Statement history of Asian American Medical Group Limited (ASX:AJJ)

31 Aug 202031 Aug 201931 Aug 201831 Aug 2017
Net Income-2.46M-2.05M1.95M-3.09M
Depreciation855.12k44.35k46.06k53.55k
Change To Netincome1.19M-751.44k-2.17M129.94k
Change To Account Receivables-485.25k296.57k2.64M-1.17M
Change To Liabilities-184k-1.85M-1.8M1.55M
Change To Inventory16.62k35.41k-27.07k25.11k
Total Cash From Operating Activities-1.07M-4.28M639.9k-2.5M
Capital Expenditures-810.17k-540.94k-712.9k-4.85k
Other Cashflows From Investing Activities1650.13k63.71k100.62k
Total Cashflows From Investing Activities-809.96k-490.81k-645.36k95.77k
Net Borrowings-488.4k-488.4k-488.4k-488.4k
Other Cashflows From Financing Activities-131.41k-16933.63k33.63k
Total Cash From Financing Activities-619.81k1.05M33.63k33.63k
Effect Of Exchange Rate99.92k-119.67k-274.15k274.38k
Change In Cash-2.4M-3.84M-245.99k-2.13M
Dividends Paid----